Paloma Pharmaceuticals

About:

Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an aberrant up-regulation of the

Website: http://palomapharma.com

Description:

Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), CNS (epilepsy and neurodegenerative diseases), antiviral (HIV/AIDS) and skin diseases (psoriasis, atopic dermatitis and photodamage/wrinkling).

Total Funding Amount:

$1.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Jamaica Plain, Massachusetts, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)palomapharma.com

Founders:

David Sherris

Number of Employees:

1-10

Last Funding Date:

2010-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai